Blog

Bloomberg Interviews Michael Wynne on Bristol Myers Deferred Adjudication

Bristol-Myers Squibb Company is an American pharmaceutical company that manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

The company was involved in an accounting scandal in 2002 that resulted in a significant restatement of revenues from 1999 to 2001.

The company entered into deferred adjudication with the U.S. Department of Justice and Securities and Exchange Commission, agreeing to pay $150 million while neither admitting nor denying guilt.

Bloomberg interviewed former U.S. Attorney Michael J. Wynne in 2006 regarding the Bristol Myers deferred adjudication.

Recent blog posts

Donating? Here’s What to Know to Comply with Campaign Donation Laws – and When to Talk to a Lawyer

The national and state 2020 elections may go down in history as the most important ones ever. Those who have the means are tempted to donate large sums of money to their favorite candidate. They...

Read More +

What to Know About 2020 Federal Election Campaign Laws

If you're involved in an election campaign and receiving campaign donations on behalf of your favorite political candidate for federal office, there are some precautions you need to take to be sure you do not...

Read More +

Wynne Interviewed for Tribeca Film Festival Documentary on Melissa Lucio’s Death Row Case

Wynne Sheds Light on Melissa Lucio's Complex Case Former federal prosecutor Michael J. Wynne provided his expert opinion for the documentary "The State of Texas vs. Melissa," which debuted at the Tribeca Film Festival and...

Read More +

Contact Us

Get powerful legal representation. Contact Michael J. Wynne to begin your defense now.

123